Trigona Chemical Synthesis

What Trigona Chemical Synthesis does

Trigona GmbH, doing business as Trigona Chemical Synthesis, is a privately held German contract development and manufacturing organization (CDMO) founded in 2000 and headquartered at Industriepark Kalle-Albert in Wiesbaden. The company provides custom synthesis, route scouting, scale-up, analytical testing, and contract manufacturing services to pharmaceutical, specialty chemical, agrochemical, OLED, surface coating, and membrane production customers. Operations are conducted across three laboratories, three explosion-protected plants, and a dedicated analytical laboratory, with multi-purpose reactors ranging from 2L to 250L and a permitted production capacity of 30 tons per year under Germany's BImSchG (Federal Immission Control Act). The company is ISO 9001:2015 certified (recertified April 2025), operates GMP-compliant structures, and holds TÜV-inspected explosion-protection certifications.

Trigona's core technology platform is built around classical synthetic chemistry and process engineering rather than software or AI. Capabilities span organic, inorganic, polymer, and specialty chemistry, supported by in-house instrumentation including a Jeol 400 MHz NMR spectrometer (commissioned October 2023), HPLC, UV/VIS, DSC, and Karl Fischer coulometry for method development, validation, and GMP-compliant documentation. The company recently upgraded its reactor system with closed-loop cooling (TÜV-certified December 2025) and relocated within Industriepark Kalle-Albert in November 2025, signaling ongoing capital reinvestment into production capacity.

Commercially, Trigona operates a B2B enterprise field-sales model with quote-based pricing, 30-day payment terms, and project-based contracts ranging from milligram-scale research to multi-kilogram and multi-ton production. The company is represented in Japan through Central Chemicals Co., Inc. in Tokyo, enabling East Asian market access without a wholly-owned subsidiary. Ownership remains concentrated among the two founders, Dr. Günter Krummel and Dr. Peter Schade, with management transitioned to Sarah Schade in 2023; there is no evidence of external institutional investment, M&A, or public market activity.

Name

Trigona Chemical Synthesis

Legal name

Trigona GmbH

Website

https://trigona.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

11–50 employees

Short description

Trigona GmbH is a privately held German CDMO founded in 2000 that provides custom chemical synthesis, scale-up, analytical testing, and contract manufacturing to pharmaceutical, specialty chemical, agrochemical, OLED, and advanced materials customers from its Wiesbaden facility.

Ownership category

akta.pro rank

Headquarters

HQ city

Wiesbaden

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain

Revenue model

1. Contract Manufacturing / Toll Synthesis: Trigona manufactures customer-specific chemical intermediates and final products under controlled conditions. They offer flexible production volumes from milligram to multi-kilogram scale, with GMP-compliant options. This includes exclusive synthesis, production under license, and long-term supply partnerships.
2. Chemical Research & Development Services: Route scouting, literature research, detailed synthesis planning, and raw material procurement. Process optimization services including reaction condition optimization, yield improvement, and purity enhancement. Economic analysis and process robustness evaluation.
3. Analytical Testing Services: External raw material and product testing, substance analysis via NMR and HPLC, incoming inspections, quality control for manufactured products, purity and stability testing, and documented quality standards. Method development, validation, and qualification services.
4. Scale-Up & Process Development: Systematic transfer of laboratory syntheses to kilogram scale with step-by-step batch size increase. Process robustness assessment, safety evaluation, and documentation services. Reproducible batch production with close customer collaboration.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Trigona is a B2B contract manufacturing and custom synthesis provider delivering chemical intermediates and final products for pharmaceutical, specialty chemical, and research customers. Services span the full lifecycle from route scouting and process optimization through laboratory-to-kilogram scale-up, multi-purpose reactor production under BImSchG permits, and analytical testing with NMR and HPLC. Production operates from milligram to multi-ton scale, with GMP-compliant structures and ISO 9001:2015 certified quality management.

Product overview

Trigona Chemical Synthesis offers a comprehensive portfolio of chemical synthesis services spanning research, development, scale-up, and manufacturing. The company operates as a single unified service offering with five interconnected core services: Chemical Research & Optimization (synthesis route development and reaction optimization), Chemical Development & Scale-Up (laboratory to kilogram production), Custom Synthesis (contract manufacturing including GMP-compliant macromer production under BImSchG permits), Analytical Services (quality control using NMR, HPLC, and other instrumentation), and Technical Equipment (small chemical plant design and construction). The company specializes in producing intermediates, final products, research compounds, analytical standards, cold isotopomers, metabolites, and screening compounds across organic, inorganic, polymer, and specialty chemistry disciplines.

Differentiator

Problem solved

Functional benefit

Products and services

• Chemical Research & Optimization
• Chemical Development & Scale-Up
• Manufactures and Custom Synthesis
• Analytical Services
• Technical Equipment

Quantifiable outcome

• 30 tons per year production capacity for dedicated plant under BImSchG permit
• +2 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Central Chemicals Co., Inc.coreChannel Partner/ Reseller/ DistributorCentral Chemicals Co., Inc. serves as Trigona's exclusive representation partner for Japan. Located in Tokyo's Chuo-ku district, they handle customer inquiries and business relationships for the Japanese market. This partnership enables Trigona to serve Japanese customers with local support, facilitating communication and project coordination for contract synthesis and custom manufacturing services.

Scale indicators5 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Hovione: Portuguese-headquartered contract development and manufacturing organization (CDMO) specializing in active pharmaceutical ingredient synthesis, particle engineering, and custom chemical manufacturing for pharma customers. Closely comparable to Trigona as a privately held, science-driven custom synthesis services provider serving regulated pharma end markets.
• Carbogen Amcis: Swiss-based CDMO offering custom synthesis, process development, and GMP-compliant manufacturing of APIs and intermediates. Directly comparable to Trigona in offering integrated route scouting through scale-up services for pharmaceutical customers.
• Regis Technologies: US-based custom chemical manufacturer offering contract synthesis, chiral separations, and GMP API manufacturing. Comparable to Trigona as a privately held specialty custom synthesis firm with comparable scale and pharmaceutical customer focus.
• PCI Synthesis: US-based contract development and manufacturing organization providing custom synthesis, process development, and cGMP manufacturing for pharmaceutical intermediates. Closely comparable to Trigona as a privately held, science-focused custom synthesis services provider serving regulated pharma customers.

Others

• Eurofins Scientific: Global analytical testing and contract laboratory services provider with significant NMR, HPLC, and custom analytical offerings. Comparable to Trigona's analytical services line (NMR, HPLC, method validation, GMP-compliant documentation) as an adjacent/thematically related testing services provider rather than direct manufacturing competitor.

Broad incumbents

• Asymchem: Chinese-headquartered CDMO providing contract development and manufacturing of APIs, intermediates, and custom synthesis for global pharma customers. Comparable to Trigona in service scope (custom synthesis, process development, GMP manufacturing) but at substantially larger scale and broader geographic footprint.
• WuXi STA (WuXi AppTec): Global CRO/CDMO providing end-to-end custom synthesis, process development, and commercial manufacturing services. Comparable to Trigona across the full custom synthesis lifecycle but operates at vastly larger scale across multiple continents.
• Cambrex: US-headquartered CDMO providing contract development and manufacturing services for small molecule APIs and intermediates across multiple global sites. Comparable to Trigona in offering custom synthesis and process development, but at significantly greater scale (private-equity-owned, multi-thousand-ton capacity).
• Aptuit (Evotec): Drug discovery and development services company (Aptuit acquired by Evotec) offering integrated CMC, custom synthesis, and process chemistry. Comparable to Trigona in process development and custom synthesis scope, but operating within a much larger drug development platform.

Emerging players

• ChemPartner: China-based CRO/CDMO offering custom synthesis, medicinal chemistry, and process R&D services. Comparable to Trigona in custom synthesis and process development offerings, with partial overlap in pharma/specialty chemical customer base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/trigona-chemical-synthesis-gmbh

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Trigona Chemical Synthesis